Bank Of New York Mellon Corp Abeona Therapeutics Inc. Transaction History
Bank Of New York Mellon Corp
- $529 Trillion
- Q2 2025
A detailed history of Bank Of New York Mellon Corp transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Bank Of New York Mellon Corp holds 212,179 shares of ABEO stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
212,179
Previous 121,452
74.7%
Holding current value
$1.02 Million
Previous $578 Million
108.47%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ABEO
# of Institutions
101Shares Held
31.4MCall Options Held
2.42MPut Options Held
212K-
Nantahala Capital Management, LLC New Canaan, CT4.37MShares$21 Million1.08% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.07MShares$14.8 Million0.03% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.68MShares$12.9 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$12.1 Million0.0% of portfolio
-
Western Standard LLC Los Angeles, CA2.09MShares$10.1 Million6.61% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $28.6M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...